Ozempic, Wegovy: India's cheap weight-loss drugs could reshape global obesity fight
GS3Economy · S&T · Environment · Security· Industry, investment & MSMEs· Prelims + Mains·
Why in news
Indian pharmaceutical companies are preparing to launch generic versions of semaglutide-based drugs (Wegovy and Ozempic) following the expiration of their patents.
Background
Major Indian drugmakers including Cipla, Sun Pharma, and Dr Reddy's Laboratories are preparing to release generic versions of semaglutide. Analysts predict a domestic market potential of $1 billion for these weight-loss drugs in India.
Facts for Prelims
- FactSemaglutide is the molecule behind the weight-loss drugs Wegovy and Ozempic.
- FactIndian drugmakers aim to potentially slash prices of generic semaglutide by more than half.
- FactThe domestic market for weight-loss drugs in India is predicted to reach $1 billion.
For Mains
Q. Discuss how India's generic pharmaceutical industry can leverage patent expirations to address global healthcare inequities and enhance its position in the global value chain.
Dimensions to cover in your answer
- Market dynamics: Transition from high-cost branded drugs to affordable generics for obesity management
- Global health equity: Expanding access to chronic disease management through India's low-cost manufacturing
- R&D vs. Generics: Balancing the role of generic production with the need for indigenous innovation in biotech
Keywords: Generic drugs · Patent expiration · Pharmaceutical manufacturing · Global health equity · Market penetration
More Economy notes
- Income Tax Act 2025 cash rules explained: What are the key changes proposed? · 25 March 2026
- Private sector growth hits 3.5-year low in March · 24 March 2026
- Assembly Elections LIVE updates: ECI approves transfer of returning officers for West Bengal polls · 24 March 2026
- 10-year yield sees steepest one-day jump since Oct 2023 · 24 March 2026
- Sebi approves tighter conflict code, easier FPI settlement plan · 24 March 2026
- Coal India board approves up to 35% divestment in SECL, Mahanadi Coalfields · 23 March 2026
This note is generated automatically from SatyaDheesh's news feed and mapped to the UPSC CSE syllabus. Check facts against the original report or PIB before using them in an answer.